Harri Jarvelainen, DVM, Ph.D., Prof, has more than 20 years of diverse scientific, managerial and executive experience, including >15 years in pharmaceutical industry – covering the development of small molecules, peptides and biologicals from discovery to early development in multiple therapeutic areas. Contribution to more than 30 first-in-man projects.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Ractigen Therapeutics | Chief Operating Officer | Jan 1, 2023 | — | Detail |